// App-Quantinova.ai

TCT-841 : Baseline characteristics and 3-month outcomes of the EVOLVE Short DAPT Trial: A prospective investigation of abbreviated antiplatelet therapy in high bleeding risk patients treated with a thin-strut bioabsorbable polymer-coated, everolimus-eluting coronary stent

Researchers

Presenter

  • Ajay Jayant Kirtane

Principal Investigators

  • Laura Mauri

  • Robert Stoler

  • Robert Feldman

  • Franz-Josef Neumann

  • Loukas Boutis

  • Naeem Tahirkheli

  • Ralph Toelg

  • Islam Othman

  • Bernardo Stein

  • Stephan Windecker

  • Robert Yeh

  • Harold Dauerman

  • Matthew Price

  • Paul Underwood

  • Dominic Allocco

  • Ian Meredith

  • Dean Kereiakes

Medical Centers

  • Oklahoma Heart Hospital, Oklahoma City, Oklahoma, United States

  • Cardiology, University Heart Center Freiburg/Bad Krozingen, Bad Krozingen, Germany

  • University Hospital of Bern, Bern, Switzerland

  • Mediquest Research at Munroe Regional Medical Center, Ocala, Florida, United States

  • Medtronic, Boston, Massachusetts, United States

  • Morton Plant Mease Healthcare System, Clearwater, Florida, United States

  • Columbia University/New York-Presbyterian Hospital, New York, New Jersey, United States

  • Scripps Clinic, La Jolla, California, United States

  • The Christ Hospital, Cincinnati, Ohio, United States

  • University of Vermont College of Medicine, Burlington, Vermont, United States

  • Baylor Heart & Vascular Hospital, Dallas, Texas, United States

  • North Shore University Hospital, manhasset, New York, United States

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

  • WakeMed Health and Hospitals Raleigh North Carolina United States

  • Herzzentrum Segeberger Kliniken, Bad Segeberg, Germany

Locations

  • United States

  • Switzerland

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

  • Nephrology

  • Blood/haematological Diseases

Disease

  • Myocardial infarction

  • Renal insufficiency

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved